Featured Research

from universities, journals, and other organizations

Predicting aggressive lymphoma

August 25, 2014
University of Oslo
A new statistical genetic analysis can detect when lymphoma will be aggressive, researchers report, thereby, allowing treatment to be initiated in time. The statistical method will be able to determine who will need a bone-marrow transplantation and who can be spared the extreme burden that this excruciating treatment entails.

Harald Holte (from left), Erlend Smeland, Marianne Brodtkorb and Ole Christian Lingjærde have developed a new statistical method that can predict when lymphoma will become aggressive.
Credit: Yngve Vogt

Lymphoma afflicts more than 1000 Norwegians annually. Many of the patients are young. A completely new statistical method developed at University of Oslo in Norway now enables doctors to determine at an early stage of the disease process who will develop an aggressive variant, when it will occur and who will escape.

Related Articles

The new statistical method will be able to determine who will need a bone-marrow transplantation and who can be spared the extreme burden that this excruciating treatment entails.

The results have recently been published in Blood.

Many types of lymphoma

Lymphoma can be divided into approximately 60 subgroups. The prognoses are unpredictable. Some have no recurrence, while in others the disease recurs quickly. Some patients struggle with repeated recurrences.

Patient survival vary greatly. Some patients die within one or two years, while others survive for twenty to thirty years. Those who survive suffer from numerous symptoms. In addition, the treatment may have major adverse effects.

The two main groups of lymphoma are Hodgkin's, which primarily affects young people -- with approximately 130 cases annually -- and non-Hodgkin's, with a little less than 1000 cases annually.

In the group that develops non-Hodgkin's, 15 per cent are afflicted by cancer of the T-cells and 85 per cent by cancer of the B-cells. T-cells and B-cells are both part of the adaptive immune defense system. B and T-cells eliminate intruders in different ways. T-cells attack bacteria and viruses in particular. B-cells produce antibodies that in turn attack intruders.

Therefore, it is extremely detrimental when cancer deactivates parts of the immune defense system.

Aggressive variant

Professors Erlend Smeland and Harald Holte at the Institute of Cancer Research, UiO, and the Department of Oncology at Oslo University Hospital are among the country's foremost specialists in B-cell lymphoma. This is the largest group of lymphomas, which affects more than 800 Norwegians each year.

This form of cancer can be further subdivided into an aggressive and an indolent variant. The indolent form may develop very slowly without major discomfort for the patient, but it may gradually change in character and turn more aggressive. If so, the prognosis worsens. The change to the aggressive variant is called transformation. The question is: who will develop this transformation and who will be spared.

Three per cent develop this transformation in the course of a year. This means that after fifteen years, half of all those affected will have developed the transformation.

Predicting who will become ill

Together with Marianne Brodtkorb, a doctor at the Institute for Cancer Research and Ole Christian Lingjærde, professor and head of the research group for biomedical bioinformatics at the Institute of Informatics, the researchers have discovered a completely new method that can predict at an early stage of the disease who will have a recurrence and when the recurrence will appear.

"The point is to be able to tailor the treatment and nip the cancer in the bud, or delay or at best avoid the most burdensome treatment for those who are not at risk. Thus, many can have a milder form of treatment than they have today," Harald Holte explains.

To succeed, the researchers needed to find the genetic imprint of the different cancer variants. This was a formidable task.

Historic material

The only way to do this was to examine all the fresh frozen tissue samples from the diagnostic biobank at the Norwegian Radium Hospital back to the 1970s. Norway is one of few countries in the world where tissue samples from all cancer patients have been stored. Since a part of the biopsy have been frozen, the genetic material remains intact.

The researchers compared the genetic imprint with the course of the disease in all patients, such as how the disease developed, when the aggressive variant occurred, i.e. the transformation, and for how long the patient survived.

"We found genetic markers that can predict in the early stage of disease how the patient will fare and how the course of the disease will develop," Erlend Smeland emphasizes to the research magazine Apollon.

Found the most important genes

The researchers detected a total of 700 changes to both DNA and RNA. RNA is the active component of DNA.

Marianne Brodtkorb, who recently completed her PhD degree, investigated which of these 700 genes functioned in the same way. She found 14 genes which had the same function. Thereafter, she studied only these markers.

"This demonstrated for the first time that these 14 genes are associated with the transformation. These genes are known from other forms of lymphoma, but they have never before been linked to this type of lymphoma. With this new knowledge, we can now test known methods of treatment for this disease," Brodtkorb explains.

In addition, they have identified the range of genes that fluctuate in unison with the 14 genes. These genes reinforce the effect of the disease.

"In fact, this involves a range of 30 to 50 genes for each of the 14 genes. These ranges of genes are unrelated to the 700 initial changes that were detected."

New statistics

To compare the genetic imprints on the several thousand samples, Ole Christian Lingjærde has developed completely new statistical methods.

"We needed to use quite sophisticated statistical methods to detect the genetic signature that enables us to predict whether and when the cancer will enter an aggressive phase," Lingjærde points out.

Story Source:

The above story is based on materials provided by University of Oslo. The original article was written by Yngve Vogt. Note: Materials may be edited for content and length.

Cite This Page:

University of Oslo. "Predicting aggressive lymphoma." ScienceDaily. ScienceDaily, 25 August 2014. <www.sciencedaily.com/releases/2014/08/140825084630.htm>.
University of Oslo. (2014, August 25). Predicting aggressive lymphoma. ScienceDaily. Retrieved April 18, 2015 from www.sciencedaily.com/releases/2014/08/140825084630.htm
University of Oslo. "Predicting aggressive lymphoma." ScienceDaily. www.sciencedaily.com/releases/2014/08/140825084630.htm (accessed April 18, 2015).

Share This

More From ScienceDaily

More Health & Medicine News

Saturday, April 18, 2015

Featured Research

from universities, journals, and other organizations

Featured Videos

from AP, Reuters, AFP, and other news services

Our Love Of Puppy Dog Eyes Explained By Science

Our Love Of Puppy Dog Eyes Explained By Science

Newsy (Apr. 17, 2015) — Researchers found a spike in oxytocin occurs in both humans and dogs when they gaze into each other&apos;s eyes. Video provided by Newsy
Powered by NewsLook.com
Dr. Oz Under Fire For 'Quack Treatments' Yet Again

Dr. Oz Under Fire For 'Quack Treatments' Yet Again

Newsy (Apr. 17, 2015) — Ten doctors signed a letter urging Columbia University to drop Dr. Oz as vice chair of its department of surgery, saying he plugs "quack" treatments. Video provided by Newsy
Powered by NewsLook.com
Scientists Find Link Between Gestational Diabetes And Autism

Scientists Find Link Between Gestational Diabetes And Autism

Newsy (Apr. 17, 2015) — Researchers who analyzed data from over 300,000 kids and their mothers say they&apos;ve found a link between gestational diabetes and autism. Video provided by Newsy
Powered by NewsLook.com
Video Messages Help Reassure Dementia Patients

Video Messages Help Reassure Dementia Patients

AP (Apr. 17, 2015) — Family members are prerecording messages as part of a unique pilot program at the Hebrew Home in New York. The videos are trying to help victims of Alzheimer&apos;s disease and other forms of dementia break through the morning fog of forgetfulness. (April 17) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.


Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News


Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile

Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins